Digestive Health title image

Digestive Health

Gut & Immune Health

Digestive wellbeing is the ability to eat comfortably, maintain a regular bowel pattern, and move through the day without digestion taking too much of your attention. The experience can involve several different concerns, including meal-related discomfort, bloating, irregularity, or the need for a more settled routine. Identifying the main pattern helps make support more specific. Different parts of the digestive system have different needs. Fiber contributes to bowel function, intestinal cells rely on appropriate nutrition, and the gut’s microbial environment responds to the substances available to it. Other ingredients have more targeted uses, so a clear purpose helps distinguish one digestive approach from another. Comfort and consistency provide practical ways to follow the routine. Paying attention to how meals feel, the regularity of bowel habits, and tolerance of individual changes can help you understand what fits. The aim is a manageable approach that supports normal digestive function and works with your usual eating pattern.

Warnings

  • Persistent digestive changes need assessment: Blood in the stool, unexplained weight loss, significant pain, or persistent changes in bowel habits deserve assessment. Avoid masking these symptoms with laxatives, enzymes, or repeated cleanses.
  • Take fiber products as directed: Follow the product directions for fluids and medicine spacing. Get advice first if you have swallowing difficulties, possible bowel obstruction, or a condition that limits fluid intake.
  • Kidney disease changes supplement safety: Kidney function affects how the body handles several minerals and other ingredients. Seek individual advice before adding products, especially potassium or magnesium, if you have kidney disease or relevant medicines.
  • Check medicine interactions: Ask a pharmacist or clinician to review your exact products alongside your medicines. The ingredient, amount, and treatment determine which combinations are suitable.
Ingredient overview

Goal guidance

Lifestyle changes

Give meals enough time and keep eating patterns reasonably consistent. Gentle movement and a simple record of symptoms can help you recognize what feels comfortable and what needs adjusting.

Diet changes

Increase fiber gradually through foods you tolerate and keep fluid intake appropriate. Make one change at a time so that you can judge its effect on regularity and comfort.

Who this is for

Adults looking for support with digestive comfort, bowel regularity, and a more settled daily eating routine.

Who should be careful

Seek advice for blood in stool, unexplained weight loss, significant pain, or persistent changes. Swallowing difficulties, possible obstruction, kidney disease, pregnancy, immune suppression, and medicines can affect product choice.

Expected timeline

Digestive responses can become apparent as a new ingredient is introduced. Increase changes gradually and follow comfort, stool pattern, and tolerance over the following days and weeks.

Common mistakes

Adding large amounts of fiber or several digestive products at once can make discomfort harder to interpret. Introduce one change at a time and keep food and symptom notes simple.

Ingredients

Flax Botanicals
Impact
Highest effect
Typical dose7–21 g / day
Flaxseed provides a balanced mix of fiber that supports bowel regularity by adding bulk and softening stool. Its soluble fiber component also acts as a valuable prebiotic to nourish beneficial gut bacteria.

Study evidence

6 studies

Flaxseed may ease constipation by improving bowel regularity and stool consistency, with supportive human trials in people who already have constipation. Evidence for broader digestive benefits is less developed, and findings from flaxseed, isolated fiber and flaxseed oil are not interchangeable.

View ingredient ->
Glutamine Amino Acids
Impact
Highest effect
Typical dose5–15 g / day
Glutamine is the primary energy source for enterocytes (cells lining the intestine). It plays a crucial role in maintaining tight junction integrity, preventing intestinal permeability (often called 'leaky gut'), and supporting tissue repair within the GI tract.

Study evidence

37 studies

Glutamine may support the intestinal barrier or reduce digestive complications in some medical settings, but results vary by condition. Evidence does not establish a general digestive benefit in healthy people, and improvements in gut markers do not always translate into fewer symptoms.

View ingredient ->
Psyllium fiber Botanicals
Impact
Highest effect
Typical dose5–15 g / day
As a soluble, viscous fiber, psyllium normalizes stool by absorbing water, which can alleviate both constipation and diarrhea. It also acts as a prebiotic, fermenting in the colon to produce short-chain fatty acids like butyrate, which nourishes colon cells.

Study evidence

No published studies for this goal yet.

View ingredient ->
Vitamin A Vitamins
Impact
Highest effect
Typical dose750–3000 mcg / day
Vitamin A is critical for the differentiation of epithelial cells lining the gut and for the production of Secretory IgA (sIgA), the primary antibody that protects mucosal surfaces from pathogens. Deficiency impairs gut barrier function.

Study evidence

69 studies

Vitamin A supports the intestinal lining, and supplementation can reduce severe diarrhea-related outcomes in some at-risk children. However, effects on diarrhea are inconsistent, some regimens have increased it, and the evidence does not establish better everyday digestion from extra Vitamin A in well-nourished people.

View ingredient ->
Vitamin D Vitamins
Impact
Highest effect
Typical dose1000–4000 IU / day
Vitamin D receptors are abundant in the GI tract. This vitamin is critical for modulating the gut's immune response, reducing inflammation, and maintaining the integrity of the tight junctions between intestinal cells. Deficiency is linked to inflammatory bowel conditions.

Study evidence

49 studies

Vitamin D may improve symptoms or quality of life in some people with irritable bowel syndrome, but findings are mixed. Low vitamin D and changes in gut bacteria are linked with digestive conditions without proving that extra supplementation broadly improves digestion.

View ingredient ->
Zinc Minerals
Impact
Highest effect
Typical dose15–30 mg / day
Zinc is a key cofactor for enzymes involved in cell repair and regeneration. It plays a direct role in regulating the stability of intestinal tight junctions, and deficiency can lead to increased gut permeability. A well-absorbed form like zinc carnosine is particularly effective.

Study evidence

130 studies

Zinc can shorten childhood diarrhea and may help prevent episodes, particularly in settings where zinc deficiency is common. Benefits vary by age and context, vomiting is more frequent with supplementation, and this evidence does not establish better everyday digestion in well-nourished adults.

View ingredient ->

Studies

Explore published research for this goal.

Sources

Up to five highest-ranked published examples per ingredient. Study counts and charts include all published studies for the connection.

  1. Effects of flaxseed supplementation on functional constipation and quality of life in a Chinese population: A randomized trial.
    Sun J; Bai H; Ma J; Zhang R; Xie H; Zhang Y; Guo M; Yao J · Asia Pacific journal of clinical nutrition · 2021
    Randomized trial90 participantsFlax
  2. A randomized trial of the effects of flaxseed to manage constipation, weight, glycemia, and lipids in constipated patients with type 2 diabetes.
    Soltanian N; Janghorbani M · Nutrition & metabolism · 2022
    Randomized trial53 participantsFlax
  3. The short-term effects of olive oil and flaxseed oil for the treatment of constipation in hemodialysis patients.
    Ramos CI; Andrade de Lima AF; Grilli DG; Cuppari L · Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2015
    Randomized trial50 participantsFlax
  4. Effect of flaxseed or psyllium vs. placebo on management of constipation, weight, glycemia, and lipids: A randomized trial in constipated patients with type 2 diabetes.
    Soltanian N; Janghorbani M · Clinical nutrition ESPEN · 2020
    Randomized trial77 participantsFlax
  5. Supplementation with dairy calcium and/or flaxseed fibers in conjunction with orlistat augments fecal fat excretion without altering ratings of gastrointestinal comfort.
    Kristensen M; Juul SR; Sørensen KV; Lorenzen JK; Astrup A · Nutrition & metabolism · 2022
    Randomized trial38 participantsFlax
  6. Effect of perioperative glutamine-enriched nutritional support on patients with colorectal cancer: A systematic review and meta-analysis.
    Huang Y; Yang XZ; Qin SH; Zhang T; Xie M; Wang JW · World journal of gastrointestinal surgery · 2026
    Meta-analysis1,643 participants27 studies pooledGlutamine
  7. Glutamine prevents diarrhea in colorectal cancer patients undergoing chemotherapy or chemoradiotherapy: a meta-analysis.
    Chen L; Wang D; Meng C; Sun H; Li R; Miao G; Liu P · BMC gastroenterology · 2025
    Meta-analysis311 participants5 studies pooledGlutamine
  8. Glutamine supplementation reduces markers of intestinal permeability during running in the heat in a dose-dependent manner.
    Pugh JN; Sage S; Hutson M; Doran DA; Fleming SC; Highton J; Morton JP; Close GL · European journal of applied physiology · 2018
    Randomized trial10 participantsGlutamine
  9. Effect of glutamine supplementation on diarrhea, interleukin-8 and secretory immunoglobulin A in children with acute diarrhea.
    Yalçin SS; Yurdakök K; Tezcan I; Oner L · Journal of pediatric gastroenterology and nutrition · 2004
    Randomized trial128 participantsGlutamine
  10. Improvement of intestinal permeability with alanyl-glutamine in HIV patients: a randomized, double blinded, placebo-controlled clinical trial.
    Leite RD; Lima NL; Leite CA; Farhat CK; Guerrant RL; Lima AA · Arquivos de gastroenterologia · 2013
    Randomized trial46 participantsGlutamine
  11. Dietary vitamin A intake and the incidence of diarrhea and respiratory infection among Sudanese children.
    Fawzi WW; Herrera MG; Willett WC; Nestel P; el Amin A; Mohamed KA · The Journal of nutrition · 1995
    Cohort study28,753 participantsVitamin A
  12. Vitamin A supplementation decreases disease activity index in patients with ulcerative colitis: A randomized controlled clinical trial.
    Masnadi Shirazi K; Nikniaz Z; Masnadi Shirazi A; Rohani M · Complementary therapies in medicine · 2019
    Randomized trial150 participantsVitamin A
  13. The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women.
    Coutsoudis A; Bobat RA; Coovadia HM; Kuhn L; Tsai WY; Stein ZA · American journal of public health · 1995
    Randomized trial118 participantsVitamin A
  14. A randomized, controlled trial of vitamin A in children with severe measles.
    Hussey GD; Klein M · The New England journal of medicine · 1990
    Randomized trial189 participantsVitamin A
  15. Vitamin A supplementation reduces the monocyte chemoattractant protein-1 intestinal immune response of Mexican children.
    Long KZ; Santos JI; Estrada Garcia T; Haas M; Firestone M; Bhagwat J; Dupont HL; Hertzmark E; Rosado JL; Nanthakumar NN · The Journal of nutrition · 2006
    Randomized trial127 participantsVitamin A
  16. Effect of Vitamin D Supplementation on Human Gut Microbiota: A Systematic Review of Randomized Controlled Trials.
    Zeb F; Osaili T; Hashim M; Alkalbani N; Papandreou D; Cheikh Ismail L; Naja F; Radwan H; Hasan H; Obaid RS; Savvaidis I; AlBlooshi S; Alam I · Nutrition reviews · 2026
    Systematic review1,458 participants14 studies pooledVitamin D
  17. Vitamin D3 Induced Decrease in IL-17 and Malondialdehyde, and Increase in IL-10 and Total Antioxidant Capacity Levels in Patients with Irritable Bowel Syndrome.
    Amani R; Abbasnezhad A; Hajiani E; Cheraghian B; Abdoli Z; Choghakhori R · Iranian journal of immunology : IJI · 2018
    Randomized trial90 participantsVitamin D
  18. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.
    Abbasnezhad A; Amani R; Hajiani E; Alavinejad P; Cheraghian B; Ghadiri A · Neurogastroenterology and motility · 2018
    Randomized trial90 participantsVitamin D
  19. Maternal vitamin D intakes during pregnancy and child health outcome.
    Nasantogtokh E; Ganmaa D; Altantuya S; Amgalan B; Enkhmaa D · The Journal of steroid biochemistry and molecular biology · 2023
    Randomized trial311 participantsVitamin D
  20. Vitamin D metabolites and the gut microbiome in older men.
    Thomas RL; Jiang L; Adams JS; Xu ZZ; Shen J; Janssen S; Ackermann G; Vanderschueren D; Pauwels S; Knight R; Orwoll ES; Kado DM · Nature communications · 2020
    Cross-sectional study567 participantsVitamin D
  21. Oral zinc supplementation for the treatment of acute diarrhea in children: a systematic review and meta-analysis.
    Lamberti LM; Walker CL; Chan KY; Jian WY; Black RE · Nutrients · 2014
    Meta-analysis18,822 participants104 studies pooledZinc
  22. Zinc with oral rehydration therapy reduces stool output and duration of diarrhea in hospitalized children: a randomized controlled trial.
    Bhatnagar S; Bahl R; Sharma PK; Kumar GT; Saxena SK; Bhan MK · Journal of pediatric gastroenterology and nutrition · 2004
    Randomized trial287 participantsZinc
  23. Lower-Dose Zinc for Childhood Diarrhea - A Randomized, Multicenter Trial.
    Dhingra U; Kisenge R; Sudfeld CR; Dhingra P; Somji S; Dutta A; Bakari M; Deb S; Devi P; Liu E; Chauhan A; Kumar J; Semwal OP; Aboud S; Bahl R; Ashorn P; Simon J; Duggan CP; Sazawal S; Manji K · The New England journal of medicine · 2020
    Randomized trial4,500 participantsZinc
  24. Zinc supplementation in young children with acute diarrhea in India.
    Sazawal S; Black RE; Bhan MK; Bhandari N; Sinha A; Jalla S · The New England journal of medicine · 1995
    Randomized trial937 participantsZinc
  25. Short-course prophylactic zinc supplementation for diarrhea morbidity in infants of 6 to 11 months.
    Malik A; Taneja DK; Devasenapathy N; Rajeshwari K · Pediatrics · 2013
    Randomized trial272 participantsZinc
  26. Positive Effects of a Lecithin-Based Delivery Form of Boswellia serrata Extract in Acute Diarrhea of Adult Subjects.
    Giacosa A; Riva A; Petrangolini G; Allegrini P; Fazia T; Bernardinelli L; Peroni G; Rondanelli M · Nutrients · 2022
    Randomized trial49 participantsBoswellia
  27. Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.
    Khan I; Samson SE; Grover AK · Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2018
    Narrative reviewBoswellia
  28. Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome.
    Belcaro G; Gizzi G; Pellegrini L; Corsi M; Dugall M; Cacchio M; Feragalli B; Togni S; Riva A; Eggenhoffner R; Giacomelli L · European review for medical and pharmacological sciences · 2018
    Non-randomized trial71 participantsBoswellia
  29. Interventions for treating collagenous colitis.
    Kafil TS; Nguyen TM; Patton PH; MacDonald JK; Chande N; McDonald JW · The Cochrane database of systematic reviews · 2018
    Systematic review31 participants1 studies pooledBoswellia
  30. Interventions for treating collagenous colitis.
    Chande N; McDonald JW; MacDonald JK · The Cochrane database of systematic reviews · 2007
    Systematic review31 participants1 studies pooledBoswellia
  31. The role of enzyme supplementation in digestive disorders.
    Roxas M · Alternative medicine review : a journal of clinical therapeutic · 2009
    Narrative reviewBromelain
  32. Effects of bromelain supplementation on disease activity and quality of life in patients with ulcerative colitis: a randomized, triple-blind, placebo-controlled study.
    Delgarm P; Mokhtare M; Ebrahimi Daryani N; Abolghasemi J; Rahideh ST · Scientific reports · 2025
    Randomized trial70 participantsBromelain
  33. Curcuminoids for Metabolic Syndrome: Meta-Analysis Evidences Toward Personalized Prevention and Treatment Management.
    Nurcahyanti ADR; Cokro F; Wulanjati MP; Mahmoud MF; Wink M; Sobeh M · Frontiers in nutrition · 2022
    Meta-analysisCurcumin
  34. [Curcumin in children with autism spectrum disorder: systemic inflammation, sensory regulation, and gut-brain interaction disorders. A randomized, double-blind, placebo-controlled clinical trial (CURATEA)].
    Vergara Serpa JJ; Sumalla Cano S · Nutricion hospitalaria · 2026
    Randomized trial60 participantsCurcumin
  35. Curcumin supplementation during high-altitude exposure modulates body composition and its relationship with gut microbiota: a randomized controlled trial.
    Hu J; Fan D; Xiao C; Kang C; Shi J; Li Y; Liu J; Shen L; Lin N · Nutrition journal · 2026
    Randomized trial102 participantsCurcumin
  36. Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.
    Abalo R; Gallego-Barceló P; Gabbia D · International journal of molecular sciences · 2025
    Randomized trialCurcumin
  37. Turmeric for Treatment of Irritable Bowel Syndrome: A Systematic Review of Population-Based Evidence.
    Jafarzadeh E; Shoeibi S; Bahramvand Y; Nasrollahi E; Maghsoudi AS; Yazdi F; KarkonShayan S; Hassani S · Iranian journal of public health · 2022
    Systematic review9 studies pooledCurcumin
  38. Efficacy and Safety of Aurantii Fructus Immaturus Flavonoid Tablets in Patients with Functional Dyspepsia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial.
    Yang XN; Xiang J; Gong M; Yu B; Zhou ZH; Li HZ; Ge Y; Xie JR · Chinese journal of integrative medicine · 2026
    Randomized trial398 participantsFlavonoid
  39. Gut enterotype- and body mass index (BMI)-dependent effects of anthocyanin supplementation on gut microbiota composition in individuals at risk for cognitive decline: a randomized placebo-controlled trial.
    Seyoum Y; de Lucia C; Khalifa K; Bergland AK; Aarsland D; van der Giezen M · Gut microbes · 2025
    Randomized trial99 participantsFlavonoid
  40. Modulation of Microbiota-Derived Bile Acids Linked to Symptom Amelioration in Crohn's Disease: Insights From a Randomized Clinical Trial With Xanthohumol Supplementation.
    Jamieson PE; Gu I; Reichart NJ; Maier CS; Ho E; Sharpton TJ; Metz TO; Bradley R; Stevens JF · Molecular nutrition & food research · 2026
    Randomized trial19 participantsFlavonoid
  41. The role of the gut microbiome in the association between habitual anthocyanin intake and visceral abdominal fat in population-level analysis.
    Jennings A; Koch M; Jensen MK; Bang C; Kassubek J; Müller HP; Nöthlings U; Franke A; Lieb W; Cassidy A · The American journal of clinical nutrition · 2020
    Cross-sectional study618 participantsFlavonoid
  42. The gut microbiome mediates the association between a flavonoid-rich diet and MASLD in a population-level analysis.
    Bell W; Jennings A; Bondonno NP; Franke A; Bang C; Both M; Kassubek J; Müller HP; Borggrefe J; Lieb W; Kühn T; Cassidy A · European journal of nutrition · 2025
    Cross-sectional study531 participantsFlavonoid
  43. Oral or nasogastric maintenance therapy for diarrhoea of unknown aetiology resembling cholera.
    Nalin DR; Cash RA · Transactions of the Royal Society of Tropical Medicine and Hygiene · 1971
    Clinical trialGlycine
  44. Prevention and treatment of infectious diarrhea. Speculations on the next 10 years.
    Edelman R · The American journal of medicine · 1985
    Narrative reviewGlycine
  45. Super ORS.
    Bhattacharya SK; Dutta P; Dutta D; Chakraborti MK · Indian journal of public health · 1991
    Narrative reviewGlycine
  46. A comparative study of glycine fortified oral rehydration solution with standard WHO oral rehydration solution.
    Antony TJ; Mohan M · Indian pediatrics · 1990
    Randomized trial50 participantsGlycine
  47. Rice-powder salt solution in the treatment of acute diarrhea in young children.
    Sabchareon A; Chongsuphajaisiddhi T; Kittikoon P; Chanthavanich P · The Southeast Asian journal of tropical medicine and public health · 1993
    Randomized trial64 participantsGlycine
  48. Efficacy of oral magnesium therapy in the treatment of chronic constipation in spastic cerebral palsy children: a randomized controlled trial.
    Hassanein SMA; Deifallah SM; Bastawy HA · World journal of pediatrics : WJP · 2021
    Randomized trial100 participantsMagnesium
  49. Ca:Mg ratio, medium-chain fatty acids, and the gut microbiome.
    Fan L; Zhu X; Sun S; Yu C; Huang X; Ness R; Dugan LL; Shu L; Seidner DL; Murff HJ; Fodor AA; Azcarate-Peril MA; Shrubsole MJ; Dai Q · Clinical nutrition (Edinburgh, Scotland) · 2022
    Randomized trial240 participantsMagnesium
  50. The Magnesium-Rich Formula for Functional Constipation in Infants: a Randomized Comparator-Controlled Study.
    Benninga MA; MENA Infant Constipation Study Group; Vandenplas Y · Pediatric gastroenterology, hepatology & nutrition · 2022
    Randomized trial286 participantsMagnesium
  51. A Randomized Double-blind Placebo-controlled Trial on the Effect of Magnesium Oxide in Patients With Chronic Constipation.
    Mori S; Tomita T; Fujimura K; Asano H; Ogawa T; Yamasaki T; Kondo T; Kono T; Tozawa K; Oshima T; Fukui H; Kimura T; Watari J; Miwa H · Journal of neurogastroenterology and motility · 2022
    Randomized trial34 participantsMagnesium
  52. Magnesium treatment increases gut microbiome synthesizing vitamin D and inhibiting colorectal cancer: results from a double-blind precision-based randomized placebo-controlled trial.
    Sun E; Zhu X; Ness RM; Murff HJ; Sun S; Yu C; Fan L; Azcarate-Peril MA; Shrubsole MJ; Dai Q · The American journal of clinical nutrition · 2025
    Randomized trial240 participantsMagnesium
  53. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease.
    Belluzzi A; Brignola C; Campieri M; Pera A; Boschi S; Miglioli M · The New England journal of medicine · 1996
    Randomized trial78 participantsOmega-3
  54. Improvement in Glycolipid Metabolism Parameters After Supplementing Fish Oil-Derived Omega-3 Fatty Acids Is Associated with Gut Microbiota and Lipid Metabolites in Type 2 Diabetes Mellitus.
    Xia J; Yin S; Yu J; Wang J; Jin X; Wang Y; Liu H; Sun G · Nutrients · 2024
    Randomized trial110 participantsOmega-3
  55. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsOmega-3
  56. Weight Loss and Omega-3 Supplementation Modulate the Microbiome in Women with Increased Breast Cancer Risk.
    Cook KL; Giles ED; Sekela JJ; Simpson JB; Redinbo MR; Wilson AS; Umar S; Befort CA; Kimler BF; Hursting SD; Fabian CJ · Cancer prevention research (Philadelphia, Pa.) · 2026
    Randomized trialOmega-3
  57. Role of Anti-Inflammatory Diet and Fecal Microbiota Transplant in Psoriatic Arthritis.
    Gopalarathinam R; Sankar R; Zhao SS · Clinical therapeutics · 2024
    Randomized trialOmega-3
  58. The incidence and clinical implications of hypersensitivity to papain in an allergic population, confirmed by blinded oral challenge.
    Mansfield LE; Ting S; Haverly RW; Yoo TJ · Annals of allergy · 1985
    Clinical trial500 participantsPapain
  59. Papaya preparation (Caricol®) in digestive disorders
    Muss C, Mosgoeller W, Endler T · Neuro Endocrinology Letters · 2013
    Randomized trial76 participantsPapain
  60. Effects of hydrolyzed collagen alone or in combination with fish oil on the gut microbiome in patients with major burns.
    Salehi S; Hosseinzadeh-Attar MJ; Alipoor E; Dahmardehei M; Yaseri M; Emami MR; Siadat SD · Burns : journal of the International Society for Burn Injuries · 2024
    Randomized trial57 participantsCollagen
  61. Laparoscopic ventral rectopexy using biologic mesh for the treatment of obstructed defaecation syndrome and/or faecal incontinence in patients with internal rectal prolapse: a critical appraisal of the first 100 cases.
    Franceschilli L; Varvaras D; Capuano I; Ciangola CI; Giorgi F; Boehm G; Gaspari AL; Sileri P · Techniques in coloproctology · 2016
    Cohort study100 participantsCollagen
  62. Collagen patch cover facilitates recovery of bowel function after laparoscopic colectomy.
    Huang PY; Tsai MC; Kiu KT; Yen MH; Chang TC · BMC surgery · 2024
    Observational study241 participantsCollagen
  63. Protection of the Human Gut Microbiome From Antibiotics.
    de Gunzburg J; Ghozlane A; Ducher A; Le Chatelier E; Duval X; Ruppé E; Armand-Lefevre L; Sablier-Gallis F; Burdet C; Alavoine L; Chachaty E; Augustin V; Varastet M; Levenez F; Kennedy S; Pons N; Mentré F; Andremont A · The Journal of infectious diseases · 2019
    Randomized trial28 participantsActivated Charcoal
  64. Activated charcoal to prevent irinotecan-induced diarrhea in children.
    Sergio GC; Félix GM; Luis JV · Pediatric blood & cancer · 2008
    Non-randomized trial22 participantsActivated Charcoal
  65. [Controlled clinical testing of an antidiarrheal].
    Dorn M · MMW Fortschritte der Medizin · 2006
    Randomized trial100 participantsActivated Charcoal
  66. Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
    Michael M; Brittain M; Nagai J; Feld R; Hedley D; Oza A; Siu L; Moore MJ · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2004
    Single-arm trial28 participantsActivated Charcoal
  67. Efficacy of activated charcoal in reducing intestinal gas: a double-blind clinical trial.
    Jain NK; Patel VP; Pitchumoni CS · The American journal of gastroenterology · 1986
    Non-randomized trial99 participantsActivated Charcoal
  68. Prevention of acute radiation-induced Proctitis by Aloe vera: a prospective randomized, double-blind, placebo controlled clinical trial in Pelvic Cancer patients.
    Sahebnasagh A; Ghasemi A; Akbari J; Alipour A; Lashkardoost H; Ala S; Hosseinimehr SJ; Salehifar E · BMC complementary medicine and therapies · 2020
    Randomized trial42 participantsAloe
  69. Successful Treatment of Acute Radiation Proctitis with Aloe Vera: A Preliminary Randomized Controlled Clinical Trial.
    Sahebnasagh A; Ghasemi A; Akbari J; Alipour A; Lashkardoost H; Ala S; Salehifar E · Journal of alternative and complementary medicine (New York, N.Y.) · 2017
    Randomized trial20 participantsAloe
  70. Aloe vera for Prevention of Acute Radiation Proctitis in Colorectal Cancer a Preliminary Randomized, Placebo-Controlled Clinical Trial.
    Sahebnasagh A; Saghafi F; Ghasemi A; Akbari J; Alipour A; Habtemariam S; Safdari M; Ghaleno HR; Salehifar E · Journal of gastrointestinal cancer · 2022
    Randomized trial20 participantsAloe
  71. A Pilot Study of the Effect of Aloe barbadensis Mill. Extract (AVH200®) in Patients with Irritable Bowel Syndrome: a Randomized, Double-Blind, Placebo-Controlled Study.
    Størsrud S; Pontén I; Simrén M · Journal of gastrointestinal and liver diseases : JGLD · 2016
    Randomized trial68 participantsAloe
  72. A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life.
    Hutchings HA; Wareham K; Baxter JN; Atherton P; Kingham JG; Duane P; Thomas L; Thomas M; Ch'ng CL; Williams JG · ISRN gastroenterology · 2011
    Randomized trial110 participantsAloe
  73. Betaine regulates the gut-liver axis: a therapeutic approach for chronic liver diseases.
    Perumal SK; Arumugam MK; Osna NA; Rasineni K; Kharbanda KK · Frontiers in nutrition · 2026
    Narrative reviewBetaine Anhydrous
  74. Efficacy and safety of steamed ginger extract for gastric health: a randomized, double-blind, placebo-controlled multi-center clinical trial.
    Baek HI; Ha NR; Kim C; Im TJ; Kim YY; Hwang SH; Bae JW · Food & function · 2025
    Randomized trial80 participantsGinger
  75. The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial.
    Foshati S; Poursadeghfard M; Heidari Z; Amani R · BMC complementary medicine and therapies · 2023
    Randomized trial52 participantsGinger
  76. A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Comparative Clinical Study to Evaluate the Efficacy and Safety of OLNP-06 versus Placebo in Subjects with Functional Dyspepsia.
    Panda MPharm SK; Nirvanashetty PhD S; Parachur BTech VA; Krishnamoorthy MPharm C; Dey MSc S · Journal of dietary supplements · 2022
    Randomized trial50 participantsGinger
  77. Ginger on Human Health: A Comprehensive Systematic Review of 109 Randomized Controlled Trials.
    Anh NH; Kim SJ; Long NP; Min JE; Yoon YC; Lee EG; Kim M; Kim TJ; Yang YY; Son EY; Yoon SJ; Diem NC; Kim HM; Kwon SW · Nutrients · 2020
    Systematic review109 studies pooledGinger
  78. [Is ginger a relevant antiemetic for postoperative nausea and vomiting?].
    Morin AM; Betz O; Kranke P; Geldner G; Wulf H; Eberhart LH · Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS · 2004
    Meta-analysis538 participantsGinger
  79. The gut microbial profile and circulating metabolism are associated with functional constipation in children.
    Ye X; Zhang T; Zhou J; Zhao C; Wu J · Pediatric research · 2026
    Case-control study80 participantsTaurine